Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.
Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:
(12) Patent Application: | (11) CA 2179282 |
---|---|
(54) English Title: | PHARMACEUTICALS |
(54) French Title: | PRODUITS PHARMACEUTIQUES |
Status: | Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication |
(51) International Patent Classification (IPC): |
|
---|---|
(72) Inventors : |
|
(73) Owners : |
|
(71) Applicants : |
|
(74) Agent: | GOWLING WLG (CANADA) LLPGOWLING WLG (CANADA) LLP |
(74) Associate agent: | |
(45) Issued: | |
(86) PCT Filing Date: | 1994-12-14 |
(87) Open to Public Inspection: | 1995-06-29 |
Examination requested: | 2001-12-13 |
Availability of licence: | N/A |
Dedicated to the Public: | N/A |
(25) Language of filing: | English |
Patent Cooperation Treaty (PCT): | Yes |
---|---|
(86) PCT Filing Number: | PCT/EP1994/004163 |
(87) International Publication Number: | WO 1995017190 |
(85) National Entry: | 1996-06-17 |
(30) Application Priority Data: | ||||||
---|---|---|---|---|---|---|
|
A method for the treatment (including prophylaxis) of ZAP in
mammals, including humans, which method comprises administering
to the mammal in need of such treatment, an effective amount of a
compound of formula (A) or a bioprecursor, or a pharmaceutically
acceptable salt, phosphate ester and/or acyl derivative of either of the
foregoing and the use of a compound of formula (A): or a bioprecursor,
or a pharmaceutically acceptable salt, phosphate ester and/or acyl
derivative of either of the foregoing in the manufacture of a medicament
for use in the treatment (including prophylaxis) of ZAP.
Une méthode de traitement (y compris de prophylaxie) des douleurs associées au zona chez les mammifères, notamment chez l'homme, consiste à administrer au mammifère nécessitant un tel traitement une quantité efficace d'un composé de formule (A) ou d'un bioprécurseur, ou d'un sel pharmaceutiquement acceptable, d'un ester de phosphate et/ou d'un dérivé acyle du composé ou du bioprécurseur. On utilise ce composé de la formule (A) ou un bioprécurseur, ou un sel pharmacologiquement acceptable, un ester de phosphate et/ou un dérivé acyle du composé ou du bioprécurseur, dans la fabrication d'un médicament destiné à être utilisé dans le traitement (y compris la prophylaxie) des douleurs associées au zona.
Note: Claims are shown in the official language in which they were submitted.
Note: Descriptions are shown in the official language in which they were submitted.
2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.
Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.
For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee and Payment History should be consulted.
Description | Date |
---|---|
Application Not Reinstated by Deadline | 2007-02-15 |
Inactive: Dead - No reply to s.30(2) Rules requisition | 2007-02-15 |
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice | 2006-12-14 |
Inactive: IPC from MCD | 2006-03-12 |
Inactive: Abandoned - No reply to s.30(2) Rules requisition | 2006-02-15 |
Inactive: S.30(2) Rules - Examiner requisition | 2005-08-15 |
Inactive: Status info is complete as of Log entry date | 2002-03-14 |
Inactive: Application prosecuted on TS as of Log entry date | 2002-03-14 |
Letter Sent | 2002-03-05 |
Request for Examination Requirements Determined Compliant | 2001-12-13 |
All Requirements for Examination Determined Compliant | 2001-12-13 |
Application Published (Open to Public Inspection) | 1995-06-29 |
Abandonment Date | Reason | Reinstatement Date |
---|---|---|
2006-12-14 |
The last payment was received on 2005-10-12
Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following
Please refer to the CIPO Patent Fees web page to see all current fee amounts.
Fee Type | Anniversary Year | Due Date | Paid Date |
---|---|---|---|
MF (application, 3rd anniv.) - standard | 03 | 1997-12-15 | 1997-09-19 |
MF (application, 4th anniv.) - standard | 04 | 1998-12-14 | 1998-09-25 |
MF (application, 5th anniv.) - standard | 05 | 1999-12-14 | 1999-09-24 |
MF (application, 6th anniv.) - standard | 06 | 2000-12-14 | 2000-10-05 |
MF (application, 7th anniv.) - standard | 07 | 2001-12-14 | 2001-11-13 |
Request for examination - standard | 2001-12-13 | ||
MF (application, 8th anniv.) - standard | 08 | 2002-12-16 | 2002-11-18 |
MF (application, 9th anniv.) - standard | 09 | 2003-12-15 | 2003-11-05 |
MF (application, 10th anniv.) - standard | 10 | 2004-12-14 | 2004-11-08 |
MF (application, 11th anniv.) - standard | 11 | 2005-12-14 | 2005-10-12 |
Note: Records showing the ownership history in alphabetical order.
Current Owners on Record |
---|
SMITHKLINE BEECHAM P.L.C. |
Past Owners on Record |
---|
DAVID RONALD JOHN GRIFFIN |
RONALD JAMES BOON |